Overview
BigHat Biosciences is an AI protein therapeutic design platform.
Funding
Amounts as reported; USD estimates shown only when they matchListed 2 funding records. Latest funding: $75M (Series C), Sep 24, 2026.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Sep 24, 2026 | $75M · Series C | DFJ Growth, Premji Invest | 1 source Source ↗ |
Evidence BigHat Biosciences raises USD 75 million in Series C fundingOn 2026/9/24, Presspool reported that BigHat Biosciences, a US AI antibody design company, raised USD 75 million in Series C funding, led by DFJ Growth and Premji Invest. Translated source brief, not a quotation. Check the original before citing. Sources · 1
| |||
| Jul 20, 2022 | $75M · Series B | 8VC, AME Cloud Ventures, Amgen Ventures, Andreessen Horowitz, Bristol-Myers Squibb, Gaingels, GRIDS Capital, Quadrille Capital, Section 32 | No source link |
Evidence No source brief is attached to this record. Sources · 0
8VC, AME Cloud Ventures, Amgen Ventures, Andreessen Horowitz, Bristol-Myers Squibb, Gaingels, GRIDS Capital, Quadrille Capital, Section 32 | |||
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 2 valuation records.
No chartable valuation estimates yet.
2 listed records lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Sep 24, 2026 | — · Series C | DFJ Growth, Premji Invest | 1 source Source ↗ |
Evidence BigHat Biosciences raises USD 75 million in Series C fundingOn 2026/9/24, Presspool reported that BigHat Biosciences, a US AI antibody design company, raised USD 75 million in Series C funding, led by DFJ Growth and Premji Invest. Translated source brief, not a quotation. Check the original before citing. Sources · 1
| |||
| Jul 20, 2022 | — · Series B | 8VC, AME Cloud Ventures, Amgen Ventures, Andreessen Horowitz, Bristol-Myers Squibb, Gaingels, GRIDS Capital, Quadrille Capital, Section 32 | No source link |
Evidence No source brief is attached to this record. Sources · 0
8VC, AME Cloud Ventures, Amgen Ventures, Andreessen Horowitz, Bristol-Myers Squibb, Gaingels, GRIDS Capital, Quadrille Capital, Section 32 | |||
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchNo revenue records are listed yet.
No revenue rows to list.
Team, products & investors
Explore
More Industry apps companies
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
AI蛋白质治疗设计平台 BigHat Biosciences是一个AI蛋白质治疗设计平台